Cryosite Limited (ASX:CTE)
Australia
· Delayed Price · Currency is AUD 1.200
0.00 (0.00%)
At close: Mar 9, 2026
Cryosite Revenue
Cryosite had revenue of 8.27M AUD in the half year ending December 31, 2025, with 29.23% growth. This brings the company's revenue in the last twelve months to 15.75M, up 22.56% year-over-year. In the fiscal year ending June 30, 2025, Cryosite had annual revenue of 14.12M with 11.93% growth.
Revenue (ttm)
15.75M
Revenue Growth
+22.56%
P/S Ratio
3.72
Revenue / Employee
629.96K
Employees
25
Market Cap
58.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 14.12M | 1.50M | 11.93% |
| Jun 30, 2024 | 12.61M | 677.00K | 5.67% |
| Jun 30, 2023 | 11.94M | 178.00K | 1.51% |
| Jun 30, 2022 | 11.76M | 1.73M | 17.29% |
| Jun 30, 2021 | 10.02M | 1.10M | 12.38% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rhythm Biosciences | 1.65M |
| Microba Life Sciences | 14.90M |
| INOVIQ | 2.10M |
| BCAL Diagnostics | 2.54M |
| Genetic Signatures | 19.94M |
| Monash IVF Group | 269.39M |
| Imagion Biosystems | 73.03K |
| Australian Clinical Labs | 737.49M |